Microdosing GLP-1
$149 for a 1-month supply

LIMITED TIME: Save $50 on your first order

Redefining weight loss for real people
$149 for a 1-month supply

Struggling to make progress, even when you're doing everything right? Feeling overlooked shouldn’t be the new normal. 

• Promotes cellular energy production.
  
  
• Supports DNA health and repair.
  
  
• Required to “turn off” genes that accelerate degenerative aging processes.
  
  
• NAD+ is a required “helper” molecule for proteins that regulate other cellular functions. 

When you’ve been told you’re not the right candidate, we take a different approach.

If you’ve been turned away due to strict BMI thresholds or rigid protocols, you’re not alone. Not everyone is looking for dramatic weight loss, some just want to break through a plateau or get a little extra support.



Do More, Age Less

• Promotes cellular energy production.
  
  
• Supports DNA health and repair.
  
  
• Required to “turn off” genes that accelerate degenerative aging processes.
  
  
• NAD+ is a required “helper” molecule for proteins that regulate other cellular functions. 

B12/MIC INJECTION BENEFITS 

Feel energized while fighting off fatigue

Ignite your metabolism to support weight loss goals 

Enhance your mental clarity, focus & memory 

Support your liver to flush out toxins & naturally detox your body 

Maintain the connections between neurons (called synapses) to potentially offset the risk of Alzheimer’s*

Why Microdosing GLP-1 matters for your health

Supports Longevity: May activate biological pathways that extend GLP-1 benefits beyond weight loss to enhance overall healthspan.

What AgelessRx customers are saying

The above testimonials are from real AgelessRx customers sourced from Trustpilot.com. Your individual results might differ from the above testimonials. Testimonials are not a guarantee of future results.

Slowing aging has never been simpler

• Promotes cellular energy production.
  
  
• Supports DNA health and repair.
  
  
• Required to “turn off” genes that accelerate degenerative aging processes.
  
  
• NAD+ is a required “helper” molecule for proteins that regulate other cellular functions. 

Explore our treatments

Browse our offerings or tell us about your health goals. 

Pause or cancel anytime

Plus, enjoy ongoing support from our world-class care team.

Get medical review

Fill out a brief intake form and receive a response in 2-3 days.

Enjoy fast, free shipping

Orders are delivered anywhere in the US within 5-7 business days.

Get access to cutting edge longevity treatments without leaving the couch.

IMPORTANT SAFETY INFORMATION & COMMON SIDE EFFECTS

Microdosing GLP-1 should be used with a reduced-calorie meal plan and increased physical activity.

Do not use with other GLP-1 receptor agonist medications, or any other products containing Semaglutide.

Side effects

Microdosing GLP-1 is a low-dose Injectable Semaglutide prescription.

Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder). 

Common side effects normally go away on their own within a few days or up to 2-3 weeks. Read our blog for more tips on how to manage Semaglutide side effects. If you find that any side effects persist for longer than this or get worse over time, stop taking your medication and contact your prescriber as soon as possible.

For a full list of side effects, please review the Mayo Clinic’s GLP-1 resources.

Other important safety information

Do not use GLP-1 if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis. 

The FDA is currently evaluating whether GLP-1 medications may increase the risk of suicidal thoughts or actions. Though the FDA has found no evidence supporting this risk, patients with a history of suicidal thoughts should not take GLP-1 medications.

Do not use GLP-1 if you are pregnant or breastfeeding, or planning to become pregnant or breastfeed. 

Though rare, allergic reactions to GLP-1 medications are possible. If you notice any shortness of breath or swelling around your face, tongue, or throat after using GLP-1, stop using the medication immediately and contact emergency services right away.

As with any prescription medicine, the dose prescribed is for you and you alone. Do not, under any circumstances, allow anyone else to use your prescription.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you are taking any medications to treat diabetes, including sylfonylureas or insulin. 

Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Microdosing GLP-1 is appropriate for you.

IMPORTANT SAFETY INFORMATION & COMMON SIDE EFFECTS

Copyright 2025 by AgelessRx

OUR OFFERINGS

LEARN

CONTACT US

Compounded Semaglutide
Starting at $290/month

LIMITED TIME: Save $50 on your first order

Redefining weight loss for real people 
$149 for a 1-month supply

Struggling to make progress, even when you're doing everything right? Feeling overlooked shouldn’t be the new normal.  

A low-dose GLP-1 protocol to get past that plateau with fewer side effects, guided by licensed clinicians.

• Promotes cellular energy production.
  
  
• Supports DNA health and repair.
  
  
• Required to “turn off” genes that accelerate degenerative aging processes.
  
  
• NAD+ is a required “helper” molecule for proteins that regulate other cellular functions. 

saw at least one improvement after their first check-in*

79%

• Promotes cellular energy production.
  
  
• Supports DNA health and repair.
  
  
• Required to “turn off” genes that accelerate degenerative aging processes.
  
  
• NAD+ is a required “helper” molecule for proteins that regulate other cellular functions. 

Supports Longevity
May activate biological pathways that extend GLP-1 benefits beyond weight loss to enhance overall healthspan.

Reduces Cognitive Decline
May reduce the risk of age-related cognitive decline and dysfunction.

Stifles Inflammation
May target chronic inflammation to support joint health and reduce pain.

Combats Age-Related Diseases
May trigger molecular pathways that help prevent conditions like heart disease, neurodegeneration, and
metabolic disorders.

Why Microdosing GLP-1 matters for longevity

What AgelessRx customers
are saying

The above testimonials are from real AgelessRx customers sourced from Trustpilot.com. Your individual results might differ from the above testimonials. Testimonials are not a guarantee of future results.

Slowing aging has never been simpler

• Promotes cellular energy production.
  
  
• Supports DNA health and repair.
  
  
• Required to “turn off” genes that accelerate degenerative aging processes.
  
  
• NAD+ is a required “helper” molecule for proteins that regulate other cellular functions. 

Explore our treatments

Browse our offerings or tell us about your health goals. 

Pause or cancel anytime

Plus, enjoy ongoing support from our world-class care team.

Get medical review

Fill out a brief intake form and receive a prescriber response in 2-3 days.

Enjoy fast, free shipping

Orders are delivered anywhere in the US within 5-7 business days.

Get access to cutting edge longevity treatments without leaving the couch.

*See studies cited below.
¹J Clin Tran Endo, 2024. This review study analyzes human GLP-1 trials, including protocols via injection that may be considered low dose or microdosing.
²Aging and Disease, 2022. This review study analyzes human and animal trials of various GLP-1 medications for their role in addressing the hallmarks of aging, such as mitochondrial function and oxidative stress, including low-dose protocols via injection for Parkinson's patients on exenatide.
³NEJM, 2016. The SUSTAIN 6 clinical trial, sponsored by Novo Nordisk, explores cardiovascular outcomes for patients taking Semaglutide injections at doses as low as 0.5mg.
⁴JAMA Network, 2022. A human trial analyzing patients on Semaglutide injections that shows patients who stopped at lower doses of GLP-1 medications experienced less side effects.
⁵Lancet Diabetes Endocrinol, 2018. The results of the Novo Nordisk-sponsored SUSTAIN 7 clinical trial include weight loss outcomes for 301 participants with type 2 diabetes taking 0.5mg of Semaglutide, in addition to Metformin, showing an average of 10 pounds lost over 40 weeks. 

Reduces Cognitive Decline: May reduce the risk of age-related cognitive decline and dysfunction.

Stifles Inflammation: May target chronic inflammation to support joint health and reduce pain.

Combats Age-Related Diseases: May trigger molecular pathways that help prevent conditions like heart disease, neurodegeneration, and metabolic disorders.

How care models compare

How care models compare

Actual results may vary. Data was self-reported by 906 surveyed customers who checked in with their provider on their first check-in between 6/5/25 and 10/31/25. All respondents are AgelessRx customers who were approved for a prescription after completing an assessment with a medical provider. 
*Lancet Diabetes Endocrinol, 2018. The results of the Novo Nordisk-sponsored SUSTAIN 7 clinical trial include weight loss outcomes for 301 participants with type 2 diabetes taking 0.5mg of Semaglutide, in addition to Metformin, showing an average of 10 pounds lost over 40 weeks.

What the studies show

Study participants experienced weight loss of 10 pounds over approximately 12 weeks.

A low-dose GLP-1 protocol to get past that plateau with fewer side effects, guided by licensed clinicians.

Actual results may vary. Data was self-reported by 906 surveyed customers who checked in with their provider on their first check-in between 6/5/25 and 10/31/25. All respondents are AgelessRx customers who were approved for a prescription after completing an assessment with a medical provider. 
*Lancet Diabetes Endocrinol, 2018. The results of the Novo Nordisk-sponsored SUSTAIN 7 clinical trial include weight loss outcomes for 301 participants with type 2 diabetes taking 0.5mg of Semaglutide, in addition to Metformin, showing an average of 10 pounds lost over 40 weeks.

What the studies show

Study participants experienced weight loss of 10 pounds over approximately 12 weeks.